Is Trigyn Techno. overvalued or undervalued?

As of 7 November 2025, Trigyn Technologies has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its significant negative PE ratio of -2396.24, an EV to EBITDA of -27.79, and a Price to Book Value of 0.30. These ratios indicate underlying financial distress and a lack of profitability, which are concerning for potential investors.
In comparison to its peers, Trigyn's valuation metrics starkly contrast with TCS, which has a PE ratio of 21.53 and an EV to EBITDA of 8.37, and Infosys, with a PE ratio of 21.82 and an EV to EBITDA of 5.02. The disparity in these ratios highlights Trigyn's unfavorable position within the industry. Furthermore, the company's stock has underperformed significantly against the Sensex, with a year-to-date return of -33.25% compared to the Sensex's 6.50%, reinforcing the notion that Trigyn Technologies is currently overvalued.